GSK Secures High Blood Pressure Drug in $950 Million Deal

GSK Plc agreed to buy 35Pharma Inc., a biotech with an early-stage high blood pressure drug, as the UK pharmaceutical company expands into cardiovascular medicine....

Redirecting to full article...